Twitxy Saved

SWOG Cancer Research Network

@SWOG

SWOG Cancer Research Network runs publicly funded clinical trials that have saved 3 million+ years of life. Founded by the National Cancer Institute in 1956.
United States swog.org Joined January 2012
1.4K Following 15K Followers 15K Posts

Latest posts 5

SWOG Cancer Research Network @SWOG
Read more about this new TrialMatch AI-assisted tool for finding cancer clinical trials for patients -- and about the study underway with @theMedNet and @SWOG testing whether the tool can raise awareness of trials and increase referrals:
swog.org/news-events/ne…
Dr. Anthony Letai @NCIDirector Aug 31
I am committed to reducing administrative burdens related to cancer clinical trials. NCI SBIR-funded @theMedNet is helping with TrialMatch, a new AI-assisted tool that makes it faster and easier for doctors to find trials for their patients. go.nih.gov/uA0Cyg2
View quoted post on X
SWOG Cancer Research Network @SWOG
Ovarian reserve as measure of adjuvant chemotherapy benefit in HR-positive, HER2-negative, node-positive breast cancer in SWOG S1007 (RxPONDER)
In premenopausal pts <55yrs, AMH was significantly better indicator of chemo benefit than menopause status, age
annalsofoncology.org/article/S0923-…
www.annalsofoncology.org Ovarian reserve as a measure of adjuvant chemotherapy benefit in hormone receptor positive (HR-po... The phase 3 RxPONDER trial compared endocrine therapy (ET) alone or with chemotherapy (CET) in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer...
SWOG Cancer Research Network @SWOG
Federal and Industry Sponsorship in US Cancer Clinical Trials
A comparative study of cancer clinical trial portfolios supported by federal versus industry funding characterizes their distinct, interdependent roles. In @JAMAOncology @drjoeunger @fredhutch
jamanetwork.com/journals/jamao…
jamanetwork.com Federal and Industry Sponsorship in US Cancer Clinical Trials This comparative study of cancer clinical trial portfolios assesses differences between federal and industry sponsors in cancer clinical trial research.
SWOG Cancer Research Network @SWOG
UroToday.com Verified account @urotoday May 31
First interim analysis of SWOG S1823/GCC.1: Operating characteristics of circulating microRNA 371a-3p (miR371) in predicting active germ cell malignancy (aGCM) in patients with early-stage #TesticularCancer. Presentation by @LuciaNappi4 @VanProstateCtr. #ASCO26 written coverage by @chavarriagaj @PSH_Urology > bit.ly/4dOKJNq @ASCO @SWOG
View quoted post on X